Vanguard Group
ANIP icon

Vanguard Group’s ANI Pharmaceuticals ANIP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$83.3M Buy
1,277,354
+95,883
+8% +$6.26M ﹤0.01% 1904
2025
Q1
$79.1M Sell
1,181,471
-132,901
-10% -$8.9M ﹤0.01% 1892
2024
Q4
$72.7M Sell
1,314,372
-33,739
-3% -$1.87M ﹤0.01% 2003
2024
Q3
$80.4M Sell
1,348,111
-92,333
-6% -$5.51M ﹤0.01% 1979
2024
Q2
$91.7M Buy
1,440,444
+134,012
+10% +$8.53M ﹤0.01% 1871
2024
Q1
$90.3M Buy
1,306,432
+17,460
+1% +$1.21M ﹤0.01% 1917
2023
Q4
$71.1M Buy
1,288,972
+156,594
+14% +$8.63M ﹤0.01% 2033
2023
Q3
$65.7M Buy
1,132,378
+58,204
+5% +$3.38M ﹤0.01% 2006
2023
Q2
$57.8M Buy
1,074,174
+239,964
+29% +$12.9M ﹤0.01% 2126
2023
Q1
$33.1M Buy
834,210
+21,586
+3% +$857K ﹤0.01% 2368
2022
Q4
$32.7M Buy
812,624
+24,701
+3% +$994K ﹤0.01% 2382
2022
Q3
$25.3M Sell
787,923
-26,251
-3% -$844K ﹤0.01% 2533
2022
Q2
$24.2M Buy
814,174
+38,875
+5% +$1.15M ﹤0.01% 2550
2022
Q1
$21.8M Buy
775,299
+58,523
+8% +$1.65M ﹤0.01% 2722
2021
Q4
$33M Buy
716,776
+71,962
+11% +$3.32M ﹤0.01% 2574
2021
Q3
$21.2M Buy
644,814
+25,489
+4% +$837K ﹤0.01% 2833
2021
Q2
$21.7M Sell
619,325
-39,680
-6% -$1.39M ﹤0.01% 2794
2021
Q1
$23.8M Buy
659,005
+55,783
+9% +$2.02M ﹤0.01% 2695
2020
Q4
$17.5M Buy
603,222
+35,277
+6% +$1.02M ﹤0.01% 2705
2020
Q3
$16M Buy
567,945
+18,505
+3% +$522K ﹤0.01% 2561
2020
Q2
$17.8M Sell
549,440
-41,095
-7% -$1.33M ﹤0.01% 2476
2020
Q1
$24.1M Buy
590,535
+14,305
+2% +$583K ﹤0.01% 2199
2019
Q4
$35.5M Sell
576,230
-9,511
-2% -$587K ﹤0.01% 2259
2019
Q3
$42.7M Buy
585,741
+21,424
+4% +$1.56M ﹤0.01% 2144
2019
Q2
$46.4M Buy
564,317
+12,859
+2% +$1.06M ﹤0.01% 2137
2019
Q1
$38.9M Buy
551,458
+23,898
+5% +$1.69M ﹤0.01% 2214
2018
Q4
$23.8M Buy
527,560
+4,747
+0.9% +$214K ﹤0.01% 2373
2018
Q3
$29.6M Buy
522,813
+8,173
+2% +$462K ﹤0.01% 2398
2018
Q2
$34.4M Buy
514,640
+20,934
+4% +$1.4M ﹤0.01% 2323
2018
Q1
$28.7M Buy
493,706
+12,477
+3% +$726K ﹤0.01% 2350
2017
Q4
$31M Buy
481,229
+6,400
+1% +$412K ﹤0.01% 2305
2017
Q3
$24.9M Sell
474,829
-2,119
-0.4% -$111K ﹤0.01% 2384
2017
Q2
$22.3M Buy
476,948
+35,722
+8% +$1.67M ﹤0.01% 2404
2017
Q1
$21.8M Buy
441,226
+23,806
+6% +$1.18M ﹤0.01% 2409
2016
Q4
$25.3M Buy
417,420
+28,480
+7% +$1.73M ﹤0.01% 2316
2016
Q3
$25.8M Buy
388,940
+3,270
+0.8% +$217K ﹤0.01% 2252
2016
Q2
$21.5M Buy
385,670
+15,760
+4% +$880K ﹤0.01% 2300
2016
Q1
$12.5M Buy
369,910
+8,997
+2% +$303K ﹤0.01% 2496
2015
Q4
$16.3M Buy
360,913
+19,733
+6% +$890K ﹤0.01% 2393
2015
Q3
$13.5M Sell
341,180
-1,315
-0.4% -$52K ﹤0.01% 2452
2015
Q2
$21.3M Buy
342,495
+45,287
+15% +$2.81M ﹤0.01% 2328
2015
Q1
$18.6M Buy
297,208
+71,072
+31% +$4.45M ﹤0.01% 2356
2014
Q4
$12.8M Buy
226,136
+1,765
+0.8% +$99.5K ﹤0.01% 2434
2014
Q3
$6.35M Buy
224,371
+14,758
+7% +$417K ﹤0.01% 2712
2014
Q2
$7.22M Buy
209,613
+10,663
+5% +$367K ﹤0.01% 2666
2014
Q1
$6.24M Buy
198,950
+91,256
+85% +$2.86M ﹤0.01% 2717
2013
Q4
$2.16M Buy
107,694
+20,544
+24% +$412K ﹤0.01% 3157
2013
Q3
$852K Sell
87,150
-447,219
-84% -$4.37M ﹤0.01% 3416
2013
Q2
$535K Buy
+534,369
New +$535K ﹤0.01% 3459